Perrigo Company plc (NYSE:PRGO) Shares Purchased by Invesco Ltd.

Invesco Ltd. grew its position in Perrigo Company plc (NYSE:PRGO - Free Report) by 8.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,565,551 shares of the company's stock after acquiring an additional 117,469 shares during the quarter. Invesco Ltd. owned about 1.15% of Perrigo worth $40,250,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Headlands Technologies LLC boosted its stake in Perrigo by 1,942.0% during the 4th quarter. Headlands Technologies LLC now owns 1,409 shares of the company's stock worth $36,000 after purchasing an additional 1,340 shares during the last quarter. Versant Capital Management Inc purchased a new position in shares of Perrigo in the fourth quarter worth about $45,000. GAMMA Investing LLC boosted its position in Perrigo by 93.7% during the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company's stock worth $49,000 after acquiring an additional 929 shares during the last quarter. Central Pacific Bank Trust Division grew its stake in Perrigo by 33.3% during the 4th quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company's stock valued at $51,000 after acquiring an additional 500 shares in the last quarter. Finally, Venturi Wealth Management LLC lifted its stake in Perrigo by 97.8% in the 4th quarter. Venturi Wealth Management LLC now owns 4,215 shares of the company's stock worth $108,000 after purchasing an additional 2,084 shares in the last quarter. 95.91% of the stock is owned by institutional investors and hedge funds.

Perrigo Trading Up 1.8 %

Perrigo stock traded up $0.45 during mid-day trading on Tuesday, hitting $24.81. The company's stock had a trading volume of 900,084 shares, compared to its average volume of 1,522,399. Perrigo Company plc has a 1 year low of $23.14 and a 1 year high of $33.46. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94. The firm has a market capitalization of $3.39 billion, a PE ratio of -21.20 and a beta of 0.49. The stock's fifty day moving average is $26.49 and its two-hundred day moving average is $26.05.

Perrigo (NYSE:PRGO - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.92 by $0.01. Perrigo had a negative net margin of 3.64% and a positive return on equity of 7.38%. The firm had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.20 billion. On average, analysts anticipate that Perrigo Company plc will post 2.56 EPS for the current year.

Perrigo Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 25th. Shareholders of record on Friday, March 7th were given a $0.29 dividend. This is a positive change from Perrigo's previous quarterly dividend of $0.28. The ex-dividend date was Friday, March 7th. This represents a $1.16 dividend on an annualized basis and a yield of 4.68%. Perrigo's payout ratio is presently -92.80%.

Insiders Place Their Bets

In other news, EVP Ronald Craig Janish sold 7,800 shares of the firm's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the transaction, the executive vice president now owns 33,666 shares of the company's stock, valued at approximately $923,795.04. This trade represents a 18.81 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.70% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on PRGO. StockNews.com lowered Perrigo from a "buy" rating to a "hold" rating in a research report on Wednesday, February 19th. Argus downgraded Perrigo from a "buy" rating to a "hold" rating in a research note on Tuesday, January 14th. Finally, Piper Sandler cut shares of Perrigo from an "overweight" rating to a "neutral" rating and lowered their price target for the company from $34.00 to $27.00 in a research report on Monday, January 6th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $33.00.

About Perrigo

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.